Thales to Enhance Vehicle Access With Reliable and Secure Contactless Solutions
Car industry players can rely on Thales to provide digital and physical solutions that improve car access experiences, while ensuring data security. Thales's offer encompasses a digital car key solution, whose implementation follows the Car Connectivity Consortium1 (CCC) standard. It is now completed by a brand-new contactless card, the Thales NFC CARd Key. The solutions enable car drivers to lock/unlock and start their vehicles using their smartphone or their card. Drawing on its 15+ years of experience in the automotive industry, Thales delivers proven on-board car solutions leveraging its connectivity and cybersecurity expertise.
Thales, a global leader in advanced technologies, provides car manufacturers with safe and hassle-free solutions to expand their customers’ vehicle access experiences. The offer leverages the digital car key solution and the smart NFC CARd Key, a new cutting-edge and customisable solution. Designed to complement the digital key, this innovative NFC-based card offers a reliable alternative in the event of disruptions on users’ smartphones, and allows drivers to unlock and start their cars with a simple ‘tap’.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241217507780/en/
Thales NFC CARd Key (Photo: Thales)
The automotive industry is rapidly shifting from traditional to digital solutions, and the digital car key market is expected to grow at an impressive annual rate of over 21% from 2023 to 20312. Thales is addressing this growing demand, leveraging the CCC digital key functionality, demonstrating strong cybersecurityexpertise into digital car key solution and securely creating and storing credentials in a vehicle, in a mobile device and/or in a contactless card.
After digitally enrolling drivers’ credentials upon the purchase of a car, Thales’s digital car key system securely allows drivers to enter and start the vehicle using their smartphone, while the mobile device is still in the pocket or in the bag. Such flexible solutions enable a wide range of automotive use cases, making car access and sharing significantly easier. Private car owners can digitally share their access with family members or friends, while car rental firms can do the same with customers, physically removing the need to pick up car keys at a rental desk. Meanwhile, the introduction of Thales’s NFC CARd Key perfectly supports scenarios when a smartphone might not be available.
Functioning like a contactless payment card, the NFC CARd Key establishes secure, encrypted communication with the vehicle, allowing instant access and engine start, just like the mobile app. With over 10 years of durability in the field, and a strong resistance to high temperatures, it ensures robust protection, while enabling a smooth and simple ‘tap-enter-and-go’ experience. Beyond its technical features, the NFC CARd Key presents a valuable branding opportunity for automotive manufacturers, as its design can be customised, creating a unique and singular card thanks to Thales's wide range of printing options (3D effect, tactile varnish, etc.).
“Thales brings over 15 years of experience in delivering connectivity and cybersecurity solutions to the automotive industry, with a deep understanding of customer requirements, from daily usage conditions to compliance with stringent standards. This extends to data security expertise in vehicles and mobile devices, providing peace of mind through a robust and resilient approach to cybersecurity,” stated Christine Caviglioli, VP Automotive at Thales. “With the launch of the NFC CARd Key, Thales complements its vehicle access offer with a singular innovation. Our ambition is to empower automakers and drivers alike with a flexible approach to secure mobility.”
1 The Car Connectivity Consortium (CCC), an organisation that promotes seamless smartphone-to-car connectivity, has set the standard for digital car keys, enabling drivers to unlock and start their vehicles using smartphones or smartwatches.
2 According to Transparency Market Research.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies specialising in three business domains: Defence, Aerospace, and Cyber & Digital.
It develops products and solutions that help make the world safer, greener and more inclusive.
The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G.
Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion.
PLEASE VISIT
View source version on businesswire.com: https://www.businesswire.com/news/home/20241217507780/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MultiBank Group Celebrates Success at Traders Fair Hong Kong 202419.12.2024 13:23:00 CET | Press release
MultiBank Group, the world’s largest financial derivatives institution headquartered in Dubai, has been recognized for its industry contributions at Traders Fair Hong Kong 2024. The company was honored with three prestigious awards: ‘Best Forex Partners Program Global 2024,’ ‘Best Forex Broker in the Philippines,’ and ‘Forex Broker of the Year.’ This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219559815/en/ MultiBank Group Wins Three Awards at Traders Fair Hong Kong (Graphic: Business Wire) Traders Fair Hong Kong is a leading financial event in Asia, bringing together thousands of traders, investors, and industry professionals from around the world. The platform showcases the latest trends, technologies, and strategies shaping global financial markets. The Group’s recognition at the event highlights its commitment to excellence and innovation in delivering top-tier financial services. The ‘Best Forex Partners Program Global
Kinaxis Announces $40,000 Academic Award to Empower the Next Generation of Supply Chain Innovators19.12.2024 13:00:00 CET | Press release
Company gives aspiring supply chain students a boost in honor of its 40th anniversary In celebration of its 40th anniversary, Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced a $40,000 academic award to help students looking to pursue careers in supply chain. Kinaxis is strengthening its partnerships with Texas Christian University, University of Toronto and Carleton University to provide each institution with a portion of the award to go towards helping students currently enrolled in supply chain, AI or computer science programs to shape the future of supply chains. The Kinaxis academic award comes at a time when the need for supply chain talent is growing. As validated by a recent IDC survey sponsored by Kinaxis, over 32% of global supply chain leaders stating the ability to attract and retain top talent with the right skills is a top concern for business continuity. “As supply chains increase in scale and complexity, cultivating the next
Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy19.12.2024 12:00:00 CET | Press release
– Treatment with the highly selective NaV1.8 pain signal inhibitor suzetrigine met the primary endpoint with a statistically significant and clinically meaningful 2.02 point within-group reduction from baseline in the Numeric Pain Rating Scale (NPRS) –– Placebo arm showed similar within-group reduction in NPRS – – Suzetrigine was generally well tolerated –– Advancement to Phase 3 inpainful lumbosacral radiculopathy planned, pending discussions with regulators – – Vertex to host investor call on December 19 at 8:00 a.m. ET – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy (LSR). The study met its primary endpoint with statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS). Efficacy Results The study’s primary endpoint was a within-group change from
Ukraine Conflict Impacting Nordics Cloud Adoption19.12.2024 10:00:00 CET | Press release
Supply chain disruptions and skilled labor shortages are intensifying enterprise demands for better business value in the short term, ISG Provider Lens™ report says The conflict in Ukraine has intensified supply chain disruptions, affecting IT investments across the Nordics, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2024 ISG Provider Lens™ Multi Public Cloud Services report for the Nordics finds companies in the region are grappling with rising IT costs and a shortage of skilled labor, which is directly impacting their cloud adoption strategies. As a result, many organizations are focusing their investments on projects the deliver immediate business value, while deferring less critical initiatives. This trend, ISG says, underscores the need for agile and efficient cloud solutions that can adapt to evolving market conditions. The demand for hybrid and multicloud soluti
Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA19.12.2024 09:00:00 CET | Press release
- Global Market Expansion Accelerates with Back-to-Back FDA and EC Authorizations Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: DMB-3115, Active Ingredient: Ustekinumab), has received marketing authorization from the European Commission (EC) as of December 18. This landmark approval comes just two months after the Committee for Medicinal Products for Human Use (CHMP) under the European Medicine Agency (EMA) recommended the product for approval in October. Combined with its successful U.S. Food and Drug Administration (FDA) approval in October, IMULDOSA is now fully authorized to enter the global market. IMULDOSA, a biosimilar referencing Stelara of Janssen Pharmaceuticals, is indicated for treating inflammatory diseases, including plaque psoriasis, psoriatic arthritis, and Crohn’s disease. Stelara, with its active ingredient ustekinumab, is among the top-grossing biologics worldwide, generating $20.323 billion in cum
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom